Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | OT |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | OT |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | OT |
Felt tired; This spontaneous report was received from a consumer and refers to a 66-year-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. He also stated that he is unsure if he received the Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) as a child. On 16-Mar-2025, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Solution for injection administered as prophylaxis by unknown route (lot # and expiration date were not reported) which was diluted with a sterile diluent, solution for injection administered by unknown route (expiration date and lot # were not reported) along with a Covid vaccine (unspecified) administered by unknown route (indication, expiration date, and lot # were not reported). On 16-Mar-2025 (also reported as after the vaccinations), the patient experienced felt tired. The patient recovered/resolved from the event on an unspecified day in March 2025. The causal relationship between the event and the suspect vaccines/sterile diluent was not provided. Lot # is being requested and will be submitted if received.